Shanghai, China

Changhe Qi

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2015-2023

Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: Innovator Changhe Qi: Pioneering Triazolo-Pyrimidine and Pyrazine Compounds

Introduction

Changhe Qi is an accomplished inventor based in Shanghai, China, with a remarkable portfolio that includes 10 patents. His work has significantly advanced the field of pharmaceutical chemistry, particularly in relation to adenosine receptor-targeting compounds.

Latest Patents

Among his latest innovations, Changhe Qi has developed novel triazolo-pyrimidine compounds designed to target adenosine receptors, specifically A1 and A2, with a particular focus on A2a. This patent highlights the potential of these compounds in the creation of pharmaceutical compositions aimed at treating various adenosine receptor-associated diseases, such as non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), prostate cancer, and breast cancer.

In addition, Changhe has also formulated innovative pyrazine compounds that serve a similar purpose in targeting adenosine receptors. Just like his triazolo-pyrimidine compounds, these pyrazine compounds have great potential in the treatment of cancer and other related diseases, broadening the horizons of therapeutic options available for patients dealing with these conditions.

Career Highlights

Throughout his career, Changhe Qi has contributed to significant advancements in medicinal chemistry. His tenure includes notable positions at Merck Sharp & Dohme Corporation, where he honed his expertise and collaborated on important projects that have furthered the field.

Collaborations

Changhe has worked alongside esteemed colleagues such as Honchung Tsui and Qingbei Zeng. Their collaboration has fostered innovative research and shared insights that have been instrumental in developing new compounds for addressing serious medical conditions.

Conclusion

Changhe Qi's dedication to innovation in pharmaceutical chemistry through his inventions of triazolo-pyrimidine and pyrazine compounds showcases his commitment to improving healthcare outcomes. With a portfolio that continues to expand, his contributions are poised to make a significant impact in the treatment of various cancer types and other diseases related to adenosine receptors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…